First Light Asset Management, LLC Enzo Biochem Inc Transaction History

First Light Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $462,871 - $790,267	-188,159 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.81 - $5.53 $5,490 - $7,968	-1,441 Reduced 0.76%	188,159 $775,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $310,694 - $416,305	-61,402 Reduced 24.46%	189,600 $984,000
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $75,737 - $116,605	13,948 Added 5.88%	251,002 $1.38 Million
Q4 2017 Feb 14, 2018	BUY	$8.15 - $10.55 $93,219 - $120,670	11,438 Added 5.07%	237,054 $1.93 Million
Q3 2017 Nov 14, 2017	SELL	$10.45 - $11.44 $1.85 Million - $2.03 Million	-177,466 Reduced 44.03%	225,616 $2.36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	403,082	403,082 $4.45 Million

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $37M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.